Bolus Injectors
Bolus Injectors market is segmented by region (country), players, by Type and by Application. Pla ... Read More
Global and United States Microneedles for Trans & Intradermal Drug Delivery Market Report & Forecast 2024-2031
1 Study Coverage
1.1 Microneedles for Trans & Intradermal Drug Delivery Product Introduction
1.2 Global Microneedles for Trans & Intradermal Drug Delivery Outlook 2017 VS 2022 VS 2028
1.2.1 Global Microneedles for Trans & Intradermal Drug Delivery Sales in US$ Million for the Year 2017-2028
1.2.2 Global Microneedles for Trans & Intradermal Drug Delivery Sales in Volume for the Year 2017-2028
1.3 United States Microneedles for Trans & Intradermal Drug Delivery Outlook 2017 VS 2022 VS 2028
1.3.1 United States Microneedles for Trans & Intradermal Drug Delivery Sales in US$ Million for the Year 2017-2028
1.3.2 United States Microneedles for Trans & Intradermal Drug Delivery Sales in Volume for the Year 2017-2028
1.4 Microneedles for Trans & Intradermal Drug Delivery Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Microneedles for Trans & Intradermal Drug Delivery in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Microneedles for Trans & Intradermal Drug Delivery Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Microneedles for Trans & Intradermal Drug Delivery Market Dynamics
1.5.1 Microneedles for Trans & Intradermal Drug Delivery Industry Trends
1.5.2 Microneedles for Trans & Intradermal Drug Delivery Market Drivers
1.5.3 Microneedles for Trans & Intradermal Drug Delivery Market Challenges
1.5.4 Microneedles for Trans & Intradermal Drug Delivery Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Microneedles for Trans & Intradermal Drug Delivery Market Segment by Type
2.1.1 Solid Microneedles
2.1.2 Hollow Microneedles
2.1.3 Dissolvable Microneedles
2.2 Global Microneedles for Trans & Intradermal Drug Delivery Market Size by Type
2.2.1 Global Microneedles for Trans & Intradermal Drug Delivery Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Microneedles for Trans & Intradermal Drug Delivery Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Microneedles for Trans & Intradermal Drug Delivery Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Microneedles for Trans & Intradermal Drug Delivery Market Size by Type
2.3.1 United States Microneedles for Trans & Intradermal Drug Delivery Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Microneedles for Trans & Intradermal Drug Delivery Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Microneedles for Trans & Intradermal Drug Delivery Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Microneedles for Trans & Intradermal Drug Delivery Market Segment by Application
3.1.1 Drugs
3.1.2 Vaccines
3.1.3 Proteins
3.1.4 Peptides
3.1.5 Others
3.2 Global Microneedles for Trans & Intradermal Drug Delivery Market Size by Application
3.2.1 Global Microneedles for Trans & Intradermal Drug Delivery Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Microneedles for Trans & Intradermal Drug Delivery Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Microneedles for Trans & Intradermal Drug Delivery Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Microneedles for Trans & Intradermal Drug Delivery Market Size by Application
3.3.1 United States Microneedles for Trans & Intradermal Drug Delivery Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Microneedles for Trans & Intradermal Drug Delivery Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Microneedles for Trans & Intradermal Drug Delivery Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Microneedles for Trans & Intradermal Drug Delivery Competitor Landscape by Company
4.1 Global Microneedles for Trans & Intradermal Drug Delivery Market Size by Company
4.1.1 Top Global Microneedles for Trans & Intradermal Drug Delivery Manufacturers Ranked by Revenue (2021)
4.1.2 Global Microneedles for Trans & Intradermal Drug Delivery Revenue by Manufacturer (2017-2022)
4.1.3 Global Microneedles for Trans & Intradermal Drug Delivery Sales by Manufacturer (2017-2022)
4.1.4 Global Microneedles for Trans & Intradermal Drug Delivery Price by Manufacturer (2017-2022)
4.2 Global Microneedles for Trans & Intradermal Drug Delivery Concentration Ratio (CR)
4.2.1 Microneedles for Trans & Intradermal Drug Delivery Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Microneedles for Trans & Intradermal Drug Delivery in 2021
4.2.3 Global Microneedles for Trans & Intradermal Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Microneedles for Trans & Intradermal Drug Delivery Manufacturing Base Distribution, Product Type
4.3.1 Global Microneedles for Trans & Intradermal Drug Delivery Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Microneedles for Trans & Intradermal Drug Delivery Product Type
4.3.3 Date of International Manufacturers Enter into Microneedles for Trans & Intradermal Drug Delivery Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Microneedles for Trans & Intradermal Drug Delivery Market Size by Company
4.5.1 Top Microneedles for Trans & Intradermal Drug Delivery Players in United States, Ranked by Revenue (2021)
4.5.2 United States Microneedles for Trans & Intradermal Drug Delivery Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Microneedles for Trans & Intradermal Drug Delivery Sales by Players (2020, 2021 & 2022)
5 Global Microneedles for Trans & Intradermal Drug Delivery Market Size by Region
5.1 Global Microneedles for Trans & Intradermal Drug Delivery Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Microneedles for Trans & Intradermal Drug Delivery Market Size in Volume by Region (2017-2028)
5.2.1 Global Microneedles for Trans & Intradermal Drug Delivery Sales in Volume by Region: 2017-2022
5.2.2 Global Microneedles for Trans & Intradermal Drug Delivery Sales in Volume Forecast by Region (2023-2028)
5.3 Global Microneedles for Trans & Intradermal Drug Delivery Market Size in Value by Region (2017-2028)
5.3.1 Global Microneedles for Trans & Intradermal Drug Delivery Sales in Value by Region: 2017-2022
5.3.2 Global Microneedles for Trans & Intradermal Drug Delivery Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Microneedles for Trans & Intradermal Drug Delivery Market Size YoY Growth 2017-2028
6.1.2 North America Microneedles for Trans & Intradermal Drug Delivery Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Microneedles for Trans & Intradermal Drug Delivery Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Microneedles for Trans & Intradermal Drug Delivery Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Microneedles for Trans & Intradermal Drug Delivery Market Size YoY Growth 2017-2028
6.3.2 Europe Microneedles for Trans & Intradermal Drug Delivery Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Microneedles for Trans & Intradermal Drug Delivery Market Size YoY Growth 2017-2028
6.4.2 Latin America Microneedles for Trans & Intradermal Drug Delivery Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Microneedles for Trans & Intradermal Drug Delivery Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Microneedles for Trans & Intradermal Drug Delivery Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Becton Dickinson
7.1.1 Becton Dickinson Corporation Information
7.1.2 Becton Dickinson Description and Business Overview
7.1.3 Becton Dickinson Microneedles for Trans & Intradermal Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Becton Dickinson Microneedles for Trans & Intradermal Drug Delivery Products Offered
7.1.5 Becton Dickinson Recent Development
7.2 Nanopass Technologies
7.2.1 Nanopass Technologies Corporation Information
7.2.2 Nanopass Technologies Description and Business Overview
7.2.3 Nanopass Technologies Microneedles for Trans & Intradermal Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Nanopass Technologies Microneedles for Trans & Intradermal Drug Delivery Products Offered
7.2.5 Nanopass Technologies Recent Development
7.3 Radius Health
7.3.1 Radius Health Corporation Information
7.3.2 Radius Health Description and Business Overview
7.3.3 Radius Health Microneedles for Trans & Intradermal Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Radius Health Microneedles for Trans & Intradermal Drug Delivery Products Offered
7.3.5 Radius Health Recent Development
7.4 Clearside Biomedical
7.4.1 Clearside Biomedical Corporation Information
7.4.2 Clearside Biomedical Description and Business Overview
7.4.3 Clearside Biomedical Microneedles for Trans & Intradermal Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Clearside Biomedical Microneedles for Trans & Intradermal Drug Delivery Products Offered
7.4.5 Clearside Biomedical Recent Development
7.5 Dr. Prausnitz Group
7.5.1 Dr. Prausnitz Group Corporation Information
7.5.2 Dr. Prausnitz Group Description and Business Overview
7.5.3 Dr. Prausnitz Group Microneedles for Trans & Intradermal Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Dr. Prausnitz Group Microneedles for Trans & Intradermal Drug Delivery Products Offered
7.5.5 Dr. Prausnitz Group Recent Development
7.6 Zosano Pharma
7.6.1 Zosano Pharma Corporation Information
7.6.2 Zosano Pharma Description and Business Overview
7.6.3 Zosano Pharma Microneedles for Trans & Intradermal Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Zosano Pharma Microneedles for Trans & Intradermal Drug Delivery Products Offered
7.6.5 Zosano Pharma Recent Development
7.7 Corium International
7.7.1 Corium International Corporation Information
7.7.2 Corium International Description and Business Overview
7.7.3 Corium International Microneedles for Trans & Intradermal Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Corium International Microneedles for Trans & Intradermal Drug Delivery Products Offered
7.7.5 Corium International Recent Development
7.8 Circassia
7.8.1 Circassia Corporation Information
7.8.2 Circassia Description and Business Overview
7.8.3 Circassia Microneedles for Trans & Intradermal Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Circassia Microneedles for Trans & Intradermal Drug Delivery Products Offered
7.8.5 Circassia Recent Development
7.9 Valeritas, Inc.
7.9.1 Valeritas, Inc. Corporation Information
7.9.2 Valeritas, Inc. Description and Business Overview
7.9.3 Valeritas, Inc. Microneedles for Trans & Intradermal Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Valeritas, Inc. Microneedles for Trans & Intradermal Drug Delivery Products Offered
7.9.5 Valeritas, Inc. Recent Development
7.10 BD Medical
7.10.1 BD Medical Corporation Information
7.10.2 BD Medical Description and Business Overview
7.10.3 BD Medical Microneedles for Trans & Intradermal Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
7.10.4 BD Medical Microneedles for Trans & Intradermal Drug Delivery Products Offered
7.10.5 BD Medical Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Microneedles for Trans & Intradermal Drug Delivery Industry Chain Analysis
8.2 Microneedles for Trans & Intradermal Drug Delivery Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Microneedles for Trans & Intradermal Drug Delivery Distributors
8.3 Microneedles for Trans & Intradermal Drug Delivery Production Mode & Process
8.4 Microneedles for Trans & Intradermal Drug Delivery Sales and Marketing
8.4.1 Microneedles for Trans & Intradermal Drug Delivery Sales Channels
8.4.2 Microneedles for Trans & Intradermal Drug Delivery Distributors
8.5 Microneedles for Trans & Intradermal Drug Delivery Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Microneedles for Trans & Intradermal Drug Delivery CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Microneedles for Trans & Intradermal Drug Delivery Market Trends
Table 3. Microneedles for Trans & Intradermal Drug Delivery Market Drivers
Table 4. Microneedles for Trans & Intradermal Drug Delivery Market Challenges
Table 5. Microneedles for Trans & Intradermal Drug Delivery Market Restraints
Table 6. Global Microneedles for Trans & Intradermal Drug Delivery Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Microneedles for Trans & Intradermal Drug Delivery Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Microneedles for Trans & Intradermal Drug Delivery Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Microneedles for Trans & Intradermal Drug Delivery Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Microneedles for Trans & Intradermal Drug Delivery Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Microneedles for Trans & Intradermal Drug Delivery Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Microneedles for Trans & Intradermal Drug Delivery Revenue Share by Manufacturer, 2017-2022
Table 13. Global Microneedles for Trans & Intradermal Drug Delivery Sales by Manufacturer, (K Units), 2017-2022
Table 14. Global Microneedles for Trans & Intradermal Drug Delivery Sales Share by Manufacturer, 2017-2022
Table 15. Global Microneedles for Trans & Intradermal Drug Delivery Price by Manufacturer (2017-2022) & (USD/Unit)
Table 16. Global Microneedles for Trans & Intradermal Drug Delivery Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Microneedles for Trans & Intradermal Drug Delivery by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microneedles for Trans & Intradermal Drug Delivery as of 2021)
Table 18. Top Players of Microneedles for Trans & Intradermal Drug Delivery in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Microneedles for Trans & Intradermal Drug Delivery Product Type
Table 20. Date of International Manufacturers Enter into Microneedles for Trans & Intradermal Drug Delivery Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Microneedles for Trans & Intradermal Drug Delivery Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Microneedles for Trans & Intradermal Drug Delivery Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Microneedles for Trans & Intradermal Drug Delivery Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Microneedles for Trans & Intradermal Drug Delivery Sales by Players, (K Units), 2020, 2021 & 2022
Table 26. United States Microneedles for Trans & Intradermal Drug Delivery Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Microneedles for Trans & Intradermal Drug Delivery Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Microneedles for Trans & Intradermal Drug Delivery Sales in Volume by Region (2017-2022) & (K Units)
Table 29. Global Microneedles for Trans & Intradermal Drug Delivery Sales in Volume Forecast by Region (2023-2028) & (K Units)
Table 30. Global Microneedles for Trans & Intradermal Drug Delivery Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Microneedles for Trans & Intradermal Drug Delivery Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Microneedles for Trans & Intradermal Drug Delivery Sales in Volume by Country (2017-2028) & (K Units)
Table 33. North America Microneedles for Trans & Intradermal Drug Delivery Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Microneedles for Trans & Intradermal Drug Delivery Sales in Volume by Region (2017-2028) & (K Units)
Table 35. Asia Pacific Microneedles for Trans & Intradermal Drug Delivery Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Microneedles for Trans & Intradermal Drug Delivery Sales in Volume by Country (2017-2028) & (K Units)
Table 37. Europe Microneedles for Trans & Intradermal Drug Delivery Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Microneedles for Trans & Intradermal Drug Delivery Sales in Volume by Country (2017-2028) & (K Units)
Table 39. Latin Americaa Microneedles for Trans & Intradermal Drug Delivery Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Microneedles for Trans & Intradermal Drug Delivery Sales in Volume by Country (2017-2028) & (K Units)
Table 41. Middle East and Africa Microneedles for Trans & Intradermal Drug Delivery Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Becton Dickinson Corporation Information
Table 43. Becton Dickinson Description and Business Overview
Table 44. Becton Dickinson Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 45. Becton Dickinson Microneedles for Trans & Intradermal Drug Delivery Product
Table 46. Becton Dickinson Recent Development
Table 47. Nanopass Technologies Corporation Information
Table 48. Nanopass Technologies Description and Business Overview
Table 49. Nanopass Technologies Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 50. Nanopass Technologies Product
Table 51. Nanopass Technologies Recent Development
Table 52. Radius Health Corporation Information
Table 53. Radius Health Description and Business Overview
Table 54. Radius Health Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 55. Radius Health Product
Table 56. Radius Health Recent Development
Table 57. Clearside Biomedical Corporation Information
Table 58. Clearside Biomedical Description and Business Overview
Table 59. Clearside Biomedical Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 60. Clearside Biomedical Product
Table 61. Clearside Biomedical Recent Development
Table 62. Dr. Prausnitz Group Corporation Information
Table 63. Dr. Prausnitz Group Description and Business Overview
Table 64. Dr. Prausnitz Group Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 65. Dr. Prausnitz Group Product
Table 66. Dr. Prausnitz Group Recent Development
Table 67. Zosano Pharma Corporation Information
Table 68. Zosano Pharma Description and Business Overview
Table 69. Zosano Pharma Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 70. Zosano Pharma Product
Table 71. Zosano Pharma Recent Development
Table 72. Corium International Corporation Information
Table 73. Corium International Description and Business Overview
Table 74. Corium International Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 75. Corium International Product
Table 76. Corium International Recent Development
Table 77. Circassia Corporation Information
Table 78. Circassia Description and Business Overview
Table 79. Circassia Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 80. Circassia Product
Table 81. Circassia Recent Development
Table 82. Valeritas, Inc. Corporation Information
Table 83. Valeritas, Inc. Description and Business Overview
Table 84. Valeritas, Inc. Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 85. Valeritas, Inc. Product
Table 86. Valeritas, Inc. Recent Development
Table 87. BD Medical Corporation Information
Table 88. BD Medical Description and Business Overview
Table 89. BD Medical Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 90. BD Medical Product
Table 91. BD Medical Recent Development
Table 92. Key Raw Materials Lists
Table 93. Raw Materials Key Suppliers Lists
Table 94. Microneedles for Trans & Intradermal Drug Delivery Customers List
Table 95. Microneedles for Trans & Intradermal Drug Delivery Distributors List
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Microneedles for Trans & Intradermal Drug Delivery Product Picture
Figure 2. Global Microneedles for Trans & Intradermal Drug Delivery Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Microneedles for Trans & Intradermal Drug Delivery Market Size 2017-2028 (US$ Million)
Figure 4. Global Microneedles for Trans & Intradermal Drug Delivery Sales 2017-2028 (K Units)
Figure 5. United States Microneedles for Trans & Intradermal Drug Delivery Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Microneedles for Trans & Intradermal Drug Delivery Market Size 2017-2028 (US$ Million)
Figure 7. United States Microneedles for Trans & Intradermal Drug Delivery Sales 2017-2028 (K Units)
Figure 8. United States Microneedles for Trans & Intradermal Drug Delivery Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Microneedles for Trans & Intradermal Drug Delivery Market Share in Global, in Volume (K Units) 2017-2028
Figure 10. Microneedles for Trans & Intradermal Drug Delivery Report Years Considered
Figure 11. Product Picture of Solid Microneedles
Figure 12. Product Picture of Hollow Microneedles
Figure 13. Product Picture of Dissolvable Microneedles
Figure 14. Global Microneedles for Trans & Intradermal Drug Delivery Market Share by Type in 2022 & 2028
Figure 15. Global Microneedles for Trans & Intradermal Drug Delivery Sales in Value by Type (2017-2028) & (US$ Million)
Figure 16. Global Microneedles for Trans & Intradermal Drug Delivery Sales Market Share in Value by Type (2017-2028)
Figure 17. Global Microneedles for Trans & Intradermal Drug Delivery Sales by Type (2017-2028) & (K Units)
Figure 18. Global Microneedles for Trans & Intradermal Drug Delivery Sales Market Share in Volume by Type (2017-2028)
Figure 19. Global Microneedles for Trans & Intradermal Drug Delivery Price by Type (2017-2028) & (USD/Unit)
Figure 20. United States Microneedles for Trans & Intradermal Drug Delivery Market Share by Type in 2022 & 2028
Figure 21. United States Microneedles for Trans & Intradermal Drug Delivery Sales in Value by Type (2017-2028) & (US$ Million)
Figure 22. United States Microneedles for Trans & Intradermal Drug Delivery Sales Market Share in Value by Type (2017-2028)
Figure 23. United States Microneedles for Trans & Intradermal Drug Delivery Sales by Type (2017-2028) & (K Units)
Figure 24. United States Microneedles for Trans & Intradermal Drug Delivery Sales Market Share in Volume by Type (2017-2028)
Figure 25. United States Microneedles for Trans & Intradermal Drug Delivery Price by Type (2017-2028) & (USD/Unit)
Figure 26. Product Picture of Drugs
Figure 27. Product Picture of Vaccines
Figure 28. Product Picture of Proteins
Figure 29. Product Picture of Peptides
Figure 30. Product Picture of Others
Figure 31. Global Microneedles for Trans & Intradermal Drug Delivery Market Share by Application in 2022 & 2028
Figure 32. Global Microneedles for Trans & Intradermal Drug Delivery Sales in Value by Application (2017-2028) & (US$ Million)
Figure 33. Global Microneedles for Trans & Intradermal Drug Delivery Sales Market Share in Value by Application (2017-2028)
Figure 34. Global Microneedles for Trans & Intradermal Drug Delivery Sales by Application (2017-2028) & (K Units)
Figure 35. Global Microneedles for Trans & Intradermal Drug Delivery Sales Market Share in Volume by Application (2017-2028)
Figure 36. Global Microneedles for Trans & Intradermal Drug Delivery Price by Application (2017-2028) & (USD/Unit)
Figure 37. United States Microneedles for Trans & Intradermal Drug Delivery Market Share by Application in 2022 & 2028
Figure 38. United States Microneedles for Trans & Intradermal Drug Delivery Sales in Value by Application (2017-2028) & (US$ Million)
Figure 39. United States Microneedles for Trans & Intradermal Drug Delivery Sales Market Share in Value by Application (2017-2028)
Figure 40. United States Microneedles for Trans & Intradermal Drug Delivery Sales by Application (2017-2028) & (K Units)
Figure 41. United States Microneedles for Trans & Intradermal Drug Delivery Sales Market Share in Volume by Application (2017-2028)
Figure 42. United States Microneedles for Trans & Intradermal Drug Delivery Price by Application (2017-2028) & (USD/Unit)
Figure 43. North America Microneedles for Trans & Intradermal Drug Delivery Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 44. North America Microneedles for Trans & Intradermal Drug Delivery Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 45. U.S. Microneedles for Trans & Intradermal Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 46. Canada Microneedles for Trans & Intradermal Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 47. Europe Microneedles for Trans & Intradermal Drug Delivery Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 48. Europe Microneedles for Trans & Intradermal Drug Delivery Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 49. Germany Microneedles for Trans & Intradermal Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. France Microneedles for Trans & Intradermal Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. U.K. Microneedles for Trans & Intradermal Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 52. Italy Microneedles for Trans & Intradermal Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 53. Russia Microneedles for Trans & Intradermal Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 54. Asia-Pacific Microneedles for Trans & Intradermal Drug Delivery Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 55. Asia-Pacific Microneedles for Trans & Intradermal Drug Delivery Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 56. China Microneedles for Trans & Intradermal Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. Japan Microneedles for Trans & Intradermal Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. South Korea Microneedles for Trans & Intradermal Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. India Microneedles for Trans & Intradermal Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Australia Microneedles for Trans & Intradermal Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Taiwan Microneedles for Trans & Intradermal Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Indonesia Microneedles for Trans & Intradermal Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Thailand Microneedles for Trans & Intradermal Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 64. Malaysia Microneedles for Trans & Intradermal Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 65. Philippines Microneedles for Trans & Intradermal Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 66. Latin America Microneedles for Trans & Intradermal Drug Delivery Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 67. Latin America Microneedles for Trans & Intradermal Drug Delivery Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 68. Mexico Microneedles for Trans & Intradermal Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 69. Brazil Microneedles for Trans & Intradermal Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 70. Argentina Microneedles for Trans & Intradermal Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 71. Middle East & Africa Microneedles for Trans & Intradermal Drug Delivery Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 72. Middle East & Africa Microneedles for Trans & Intradermal Drug Delivery Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 73. Turkey Microneedles for Trans & Intradermal Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 74. Saudi Arabia Microneedles for Trans & Intradermal Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 75. U.A.E Microneedles for Trans & Intradermal Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 76. Microneedles for Trans & Intradermal Drug Delivery Value Chain
Figure 77. Microneedles for Trans & Intradermal Drug Delivery Production Process
Figure 78. Channels of Distribution
Figure 79. Distributors Profiles
Figure 80. Bottom-up and Top-down Approaches for This Report
Figure 81. Data Triangulation
Figure 82. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Becton Dickinson Nanopass Technologies Radius Health Clearside Biomedical Dr. Prausnitz Group Zosano Pharma Corium International Circassia Valeritas, Inc. BD Medical